Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration

Ann Am Thorac Soc. 2015 Jun;12(6):960. doi: 10.1513/AnnalsATS.201505-263LE.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Endothelin Receptor Antagonists / therapeutic use*
  • Epoprostenol / analogs & derivatives*
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Pyrazoles / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Sulfonamides / therapeutic use*

Substances

  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Pyrazoles
  • Pyrimidines
  • Sulfonamides
  • Epoprostenol